Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FNL8J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,219
Award facts
- Contract value 100% obligated
- $52,219.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $52,219.06 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) with a firm fixed price structure. This non-competitive delivery order, issued on October 31, 2025, is scheduled for ultimate completion by November 3, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order represents a task under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The IDC enables the contractor to supply an extensive range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contract vehicle positions AmerisourceBergen Drug Corp to serve multiple government healthcare systems, including the Defense Health Agency and U.S. Coast Guard, as part of DLA's strategic pharmaceutical procurement approach.
Quick answers
Who was awarded contract SPE2DR26FNL8J?
SPE2DR26FNL8J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DR26FNL8J worth?
The government has obligated $52,219 on SPE2DR26FNL8J.
Is contract SPE2DR26FNL8J an order under another contract?
Yes. SPE2DR26FNL8J is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNL8J competed?
The extent of competition for SPE2DR26FNL8J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award